The following are some observations which have great predictive value in the diagnosis of Wilson’s Temperature Syndrome:
1. What are the patient’s complaints (when questioned carefully about the symptoms of Wilson’s Temperature Syndrome)?
2. In what way did the complaints come on (Separately? Together? After a stress? After successive episodes? etc.)?
3. What is the patient’s average body temperature pattern?
4. What is the patient’s nationality (See Chapter 6)?
Too much emphasis can not be placed on the answers to any one of these questions. However, when taken together they paint a very useful clinical picture. The first three questions are the most predictive and the fourth (nationality) can be considered icing on the cake. The four questions listed above can be useful in helping to predict whether or not someone has Wilson’s Temperature Syndrome (the most common cause of DTSF) as a cause of his/her symptoms of MED. However, the best indicator that a patient’s complaints are due to MED is if the symptoms disappear in two days or two weeks with normalization of the body temperature patterns. That’s a pretty good indicator that his or her symptoms were temperature related. The best indicator that a person’s MED was caused by Wilson’s Temperature Syndrome is if all of the symptoms resolved in a short period of time (often within two days or two weeks) when the body temperature patterns were normalized by the patient taking the right kind of thyroid medicine (Chapter 10) in the right way, and if the symptoms remained resolved even after the thyroid treatment was weaned. That’s a pretty good indicator that his or her abnormally low body temperature patterns were being caused by Wilson’s Temperature Syndrome and that a persistent correction had been effected. This is what is commonly known as a therapeutic trial.
The fundamental goal of medicine is to alleviate and/or correct disease and to promote good health. Since this is the fundamental goal of medicine, the value of tests can be measured on how useful they are in accomplishing that goal. Some tests are used to aid in diagnosis of problems and some are useful in the monitoring of treatment of problems. The tests for diagnosis and monitoring medical problems are frequently the same. An abnormality on the test may show what the particular problem is, thereby being helpful in diagnosis. And the returning of that same test to normal might indicate when the problem has resolved during monitoring of treatment. A good diagnostic test should be able to predict whether or not a particular person has a particular medical problem with few false negatives (people who actually do have a medical problem who are told they are normal based on the test) and few false positives (people who are told that they have a disease based on the test when in actuality they don’t). If the diagnosis is correct based on the tests, then they should be more likely to respond to the treatment of choice for that particular problem. The value of monitoring tests can be measured in how well they predict, with few false positives and false negatives, how well a patient will respond to treatment and what the eventual outcome will be. The more useful it is in predicting response and outcome, the more useful it is as a test.
As far as the diagnosis and treatment of problems involving the glands of the thyroid system, the thyroid hormone blood tests are quite useful and reliable. However, in terms of the diagnosing and monitoring symptoms of DTSF, thyroid blood tests are, and will be, extremely low in predictive value. This is especially true in terms of diagnosis of DTSF in general, as a cause of a patient’s MED symptoms, having an enormous amount of false negatives (thyroid blood tests may indicate the patient does not have DTSF when they actually do, complete with severe and debilitating symptoms of MED that respond quickly and easily to proper thyroid hormone supplementation); and in terms of directing treatment, being extremely poor predictors as to how to guide treatment for the predictable and reproducible resolution of the patient’s symptoms.
A patient’s body temperature pattern and presentation of symptoms of MED have much greater predictive value than blood tests in terms of diagnosis of DTSF, and can much better direct proper thyroid hormone therapy. Therefore, the collection of these indicators can be used to predict positive and beneficial response to therapy in approximately 95% of cases, that is, if a patient has many of the symptoms of Wilson’s Temperature Syndrome and these symptoms came on together after a severe mental, physical, or emotional stress (which is understandable, explainable, and predictable) and if the patient has a consistently low body temperature. This is true, especially if the WT3 protocol is administered in such a way as to elevate the body temperature to 98.6 degrees, on average, and to stabilize the body temperature for optimal enzyme function. Normalization of body temperature patterns correlates extremely well with resolution of Wilson’s Temperature Syndrome symptoms. So, whereas thyroid hormone blood tests have few false positives and enormous false negatives in the diagnosis of DTSF; the criterion of MED symptoms and low body temperature patterns brought on especially after periods of stress, have much fewer false negatives, have few false positives and are much more useful and are of much greater predictive value in the diagnosis and treatment of DTSF in general and Wilson’s Temperature Syndrome in specific.